Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Celldex Therapeutics buy Wolfe Research

Start price
€28.40
23.03.26 / 50%
Target price
€38.10
23.03.27
Performance (%)
-3.52%
Price
€26.60
23.03.26
Summary
This prediction is currently active. With a performance of -3.52%, the BUY prediction for Celldex Therapeutics by Wolfe_Research is down slightly. This prediction currently runs until 23.03.27. The prediction end date can be changed by Wolfe_Research at any time. Wolfe_Research has 50% into this prediction
Performance without dividends (%)
Name 1w
Celldex Therapeutics -3.52%
iShares Core DAX® -4.932%
iShares Nasdaq 100 -2.634%
iShares Nikkei 225® -4.733%
iShares S&P 500 -2.544%

Comments by Wolfe_Research for this prediction

In the thread Celldex Therapeutics diskutieren
Prediction Buy
Perf. (%) -3.52%
Target price 38.104
Change
Ends at 23.03.27

Celldex Therapeutics (CLDX) was upgraded by Wolfe Research from "peer perform" to "outperform". They now have a $44.00 price target on the stock.
Ratings data for CLDX provided by MarketBeat

Stopped prediction by Wolfe_Research for Celldex Therapeutics

buy
Celldex Therapeutics

Start price
Target price
Perf. (%)
€29.60
25.09.24
€45.76
25.09.25
-27.70%
26.09.25

buy
Celldex Therapeutics

Start price
Target price
Perf. (%)
€32.00
11.06.24
€47.50
11.06.25
-45.31%
12.06.25